Brief: Little Green Pharma Intends To Demerge Psychedelics Business
07/02/2022 21:59
Feb 8 (Reuters) - Little Green Pharma Ltd LGP.AX :
* INTENTION TO DEMERGE PSYCHEDELICS BUSINESS INTO SEPARATE
UNLISTED ENTITY, RESET MIND SCIENCES
* DEMERGER TO BE UNDERTAKEN VIA PRO-RATA, IN-SPECIE
DISTRIBUTION
OF 100% OF RESET SECURITIES TO ELIGIBLE LGP SHAREHOLDERS
* DEMERGER COMPLETION TARGETED FOR JUNE QUARTER 2022
* BOARD BELIEVES DEMERGER WILL UNLOCK STRATEGIC VALUE OF
PSYCHEDELICS BUSINESS FOR BENEFIT OF ALL SHAREHOLDERS
* INTENTION TO ALSO OFFER ELIGIBLE RESET SHAREHOLDERS
OPPORTUNITY
TO PARTICIPATE IN ENTITLEMENT OFFER TO FUND RESET OPERATIONS
Source text for Eikon: ID:nASX926tKy
Further company coverage: LGP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Little Green Pharma
See all newsBrief: Little Green Pharma Says Cannatrek In Further Discussions With TGA In Relation To Investigation
Brief: Little Green Pharma Reports Qtrly Revenue Of A$12.5 Million
Brief: Little Green Pharma Announces Updated Second Court Date
Brief: Little Green Pharma Provides Scheme Update
Brief: Little Green Pharma Announces Termination Of Proposed Sale And Leaseback Transaction